SXI Life Sciences
6.905,90
PKT
+48,39
PKT
+0,71
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
01.09.05 | Novartis halten | National-Bank AG | |
01.09.05 | Novartis buy | Merrill Lynch | |
01.09.05 | Novartis hold | SEB | |
31.08.05 | Novartis peer perform | Thomas Weisel Partners | |
31.08.05 | Novartis Outperform | Wachovia Sec | |
31.08.05 | Novartis Peer Perform | Thomas Weisel Partners | |
29.08.05 | Novartis outperform | WestLB | |
26.08.05 | Novartis halten | National-Bank AG | |
25.08.05 | Straumann | Focus Money | |
17.08.05 | Novartis kaufen | Helaba Trust | |
10.08.05 | Novartis | Weberbank | |
09.08.05 | Novartis neutral | Nasd@q Inside | |
09.08.05 | BB Biotech kaufen | Hamburger Sparkasse | |
04.08.05 | Lonza halten | Hamburger Sparkasse | |
28.07.05 | Novartis buy | Merrill Lynch | |
21.07.05 | Novartis halten | National-Bank AG | |
21.07.05 | Novartis | Zürcher Kantonalbank | |
21.07.05 | BB Biotech | Wirtschaftswoche | |
21.07.05 | Novartis Net Negative | Susquehanna Financial | |
20.07.05 | Novartis buy | Banque SYZ & CO | |
20.07.05 | Novartis | JRC | |
18.07.05 | Novartis buy | Merrill Lynch | |
15.07.05 | Novartis kaufen | Hamburger Sparkasse | |
15.07.05 | Novartis kaufen | National-Bank AG | |
15.07.05 | Novartis akkumulieren | Independent Research | |
19.07.05 | Novartis buy | Jyske Bank | |
14.07.05 | Novartis kaufen | Helaba Trust | |
14.07.05 | Novartis buy | SEB | |
14.07.05 | Novartis akkumulieren | Independent Research | |
13.07.05 | Novartis neutral | HypoVereinsbank | |
13.07.05 | Novartis outperform | Bear Stearns | |
12.07.05 | Novartis kaufen | Helaba Trust | |
12.07.05 | Novartis in-line | Goldman Sachs | |
11.07.05 | BB Biotech kaufen | Wertpapier | |
11.07.05 | Novartis neutral | Bank Sarasin & Cie | |
08.07.05 | Novartis | Weberbank | |
05.07.05 | Novartis kaufen | JRC | |
05.07.05 | Novartis buy | Jyske Bank | |
23.06.05 | Lonza underweight | Morgan Stanley | |
22.06.05 | Novartis neutral | Bank Sarasin & Cie |